In 2019, Canbay et al. proposed a score based on age, gGT, HbA1c, caspase-cleaved cytokeratin 18 fragments (M30), and adiponectin, which predicted presence or absence of NASH with a reasonable performance [41]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.